Skip to main content
. 2014 Apr 16;9(4):e94815. doi: 10.1371/journal.pone.0094815

Table 2. Multivariate Analysis of Breast Cancer-Specific Mortality (BCSM).

Variable BCSM Pairwise*
HR [95% CI] P1 value HR [95% CI] P2 value
Age of Diagnosis
20–39 1.000 [Reference]
40–59 0.784 [0.752–0.818] <.0001
60–79 0.964 [0.924–1.007] .098
Year of Diagnosis
1990–1994 1.000 [Reference]
1995–1999 0.817 [0.788–0.847] <.0001
2000–2004 0.681 [0.657–0.705] <.0001
2005–2009 0.570 [0.545–0.597] <.0001
Tumor Size
0–2 cm 1.000 [Reference]
2–5 cm 2.286 [2.223–2.350] <.0001
>5 cm 3.714 [3.551–3.885] <.0001
LN Status
Negative 1.000 [Reference]
Positive 2,811 [2.736–2.888] <.0001
ER Status
Negative 1.000 [Reference]
Positive 0.623 [0.601–0.645] <.0001
PR Status
Negative 1.000 [Reference]
Positive 0.716 [0.691–0.741] <.0001
Radiotherapy
Without RT 1.000 [Reference]
With RT 0.892 [0.870–0.915] <.0001
Laterality
Left-sided 1.000 [Reference]
Right-sided 0.988 [0.964–1.013] .331
Primary Site <.0001
UO 1.000 [Reference] 0.920 [0.880–0.961 <.0001
UI 1.242 [1.199–1.287] <.0001 1.142 [1.085–1.203] <.0001
LI 1.329 [1.270–1.391] <.0001 1.222 [1.152–1.296] <.0001
LO 1.137 [1.091–1.185] <.0001 1.046 [0.989–1.105] .117
CEN 1.087 [1.041–1.136] <.0001 1.000 [Reference]

Abbreviations: HR =  hazard ratio; CI =  confidence interval; AJCC =  American Joint Committee on Cancer; LN =  lymph node; ER =  estrogen receptor; PR =  progesterone receptor; RT =  radiotherapy; UO =  upper outer quadrant of breast; UI =  upper inner quadrant of breast; LI =  lower inner quadrant of breast; LO =  lower outer quadrant of breast; CEN =  central portion quadrant of breast.

*Pairwise comparisons were conducted to clarify the difference on HR at different primary site. P1 value, using UO as the reference, indicated best prognosis for patients with tumors at UO. From another point of view, P2 value, using CEN as the reference, indicated that patients with tumors at CEN and LO had worse prognosis than those at UO, but better prognosis than those at UI and LI.